Evidence map›Paper›PMID 33897272›Full record

ArticleBilingualism (Cambridge, England)2020

Cross-modal translation priming and iconicity effects in deaf signers and hearing learners of American Sign Language.

Megan Mott, Katherine J Midgley, Phillip J Holcomb, Karen Emmorey

Abstract read
In one paragraph

Article in Bilingualism (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Megan MottDepartment of Psychology, San Diego State University.
Katherine J MidgleyDepartment of Psychology, San Diego State University.
Phillip J HolcombDepartment of Psychology, San Diego State University.
Karen EmmoreySchool of Speech, Language and Hearing Sciences, San Diego State University.

Funding

Language, Modality and the BrainR01DC010997 · NIDCD · SAN DIEGO STATE UNIVERSITY · PI KAREN EMMOREY · 2010 to 2026
$8.6M
The Neuro-cognition of Word ComprehensionR37HD025889 · NICHD · TUFTS UNIVERSITY MEDFORD · PI HOLCOMB, PHILLIP J · 2011 to 2020
$3.7M
The cognitive neuroscience of word comprehensionR01HD025889 · NICHD · TUFTS UNIVERSITY MEDFORD · PI HOLCOMB, PHILLIP J · 1995 to 2010
$2.8M
NICHD NIH HHS R01 HD025889NICHD NIH HHS R37 HD025889NIDCD NIH HHS R01 DC010997
6 · The paper itself

Abstract

This study used ERPs to a) assess the neural correlates of cross-linguistic, cross-modal translation priming in hearing beginning learners of American Sign Language (ASL) and deaf highly proficient signers and b) examine whether sign iconicity modulates these priming effects. Hearing learners exhibited translation priming for ASL signs preceded by English words (greater negativity for unrelated than translation primes) later in the ERP waveform than deaf signers and exhibited earlier and greater priming for iconic than non-iconic signs. Iconicity did not modulate translation priming effects either behaviorally or in the ERPs for deaf signers (except in a 800-1000 ms time window). Because deaf signers showed early translation priming effects (beginning at 400ms-600ms), we suggest that iconicity did not facilitate lexical access, but deaf signers may have recognized sign iconicity later in processing. Overall, the results indicate that iconicity speeds lexical access for L2 sign language learners, but not for proficient signers.

Indexed as

iconicitylanguage learningsign languagetranslation recognition

Identifiers

PMID33897272
PMCPMC8061897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.